Subscribe to Newsletter

Genetics and epigenetics

Subspecialties Profession

Oncogenetic Pioneer

| Charlotte Barker

Sitting Down With… Robert A. Weinberg, founding member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology, USA.

Outside the Lab Oncology

The 11 Faces of AML

| Michael Schubert

Classifying AML by genetic abnormalities may yield more accurate diagnosis, prognosis and treatment

Outside the Lab Liquid biopsy

Liquid License

| Michael Schubert

FDA issues first-ever approval for liquid biopsy companion diagnostic

Diagnostics Microscopy and imaging

Virus Vision

| Michael Schubert

A new method uses fluorescent proteins to highlight virus-infected cells and shows which proteins are affected

Diagnostics Profession

Science Searches Simplified

| Elizabeth Iorns

Researcher and entrepreneur explains how she hopes to help others take a great scientific idea to reality

Subspecialties Genetics and epigenetics

Disrupting Cytogenetics in the Clinic

| George Vasmatzis

To select the right treatment for each cancer patient, we need fast, accurate and cost effective ways to characterize tumors. Now, with newly developed algorithms and protocols, mate pair sequencing could well be the tool we’ve been seeking

Diagnostics Clinical care

Waging War on Pathogens

| Nancy Hanson

Molecular diagnostics are welcome reinforcements in the raging battle against institutional infection and antibiotic resistance

Diagnostics Genetics and epigenetics

Biomarker to Predict Breast Cancer

| Michael Schubert

Ki67 in healthy breast tissue may indicate increased risk of developing the disease

Subspecialties Genetics and epigenetics

Single-Gene Source for Schizophrenia?

| Michael Schubert

Mutations in the SETD1A gene are rare, but significantly increase patients’ risk of schizophrenia and neurodevelopmental disorders

Inside the Lab Genetics and epigenetics

An On/Off Switch for Heart Attacks

| Michael Schubert

ANGPTL4 mutations can reduce patients’ risk of heart attack by up to 50 percent – so could neutralizing the gene offer a new route to prevention?

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register